AI-generated summary
The authors report on 79 patients with multiple myeloma who received high-dose melphalan before autologous transplant and daily prophylactic low-level laser therapy. Severe oral mucositis (grade III or higher) occurred in 8 patients and was associated with higher serum creatinine and older age, with more oral pain days and morphine use in the severe group. The small severe-group size and the study's design limit how firmly these associations can be interpreted.
- Participants
- 79
- Who or what was studied
- 79 patients with multiple myeloma undergoing high-dose melphalan conditioning for autologous transplant
- Wavelengths
- 660 nm
- Limits stated in the abstract
- Only 8 patients were in the severe mucositis group, and the abstract reports univariate analyses without a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 3.75 J/cm2
- Power
- 15 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Oral mucositis, Laser, Dose, Low-level laser therapy, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.